Hey what's up guys today we're going to be talking about medications that

specifically lower mortality in congestive heart failure but specifically we're

going to be touching on two new medications that aren't really talked about

all that much in the guidelines because they've been recently approved and they've been proven to reduce mortality and after all we give medications to patients with heart failure because we want to improve patient outcomes.

We want to decrease time spent in the hospital, but aside from that, we want to make sure that these

patients live longer.

Morbidity means decreased time in the hospital.

Mortality means it improves their lifespan.

So let's very quickly recap what medications have been given in the past

with the proven mortality.

Now very quickly, diastolic dysfunction right so we can separate

heart failure into diastolic dysfunction and systolic dysfunction. systolic

dysfunction means that ejection fraction is reduced.

The amount of blood that pumps out of the heart isn't normal.

Diastolic means we have a preserved ejection fraction.

So in diastolic dysfunction dysfunction we actually don't have

any medications that improve mortality outcomes or decrease mortality I should

say. So all of the medications in diastolic dysfunction are geared more towards

symptomatic control and or comorbid conditions such as hypertension, hyperlipidemia,

atrial fibrillation, things of that nature.

Cystolic dysfunction is a little bit different.

We do have medications that reduce mortality.

...